Hoster E, Kluin-Nelemans H, Hermine O, et al. Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial. ASH 59th Annual Meeting & Exhibition, abstract 153.
Duurzame remissies met ivosidenib bij IDH1-gemuteerd gerecidiveerd of refractair AML
jul 2018 | Leukemie